Grant: CIHR Fellowship
Direct Payment
$145,833.00
Trafficking Defines Plasma Membrane Levels of the Human Calcium-Sensing Receptor
EF 2010-11
Résumé
Calcium plays important roles in the functioning of the heart, muscle, brain, maintenance of bone structure, blood clotting and cell adhesion. It is no wonder that calcium levels are maintained within a narrow range, a property achieved primarily by parathyroid hormone, synthesized and secreted by the parathyroid glands. Parathyroid hormone functions to elevate calcium levels in the blood by a direct action on bone through resorption and on the kidneys causing calcium reabsorption from renal infiltrate. It also functions indirectly facilitating the conversion of vitamin D to its active form, potentiating the absorption of calcium from the gut. The main factor regulating the secretion of PTH is the calcium-sensing receptor (CaSR), which rapidly responds to small changes in blood calcium levels. Calcium-handling disorders may arise when CaSR is mutated, as appears in cases of familial hypocalciuric hypercalcemia/neonatal severe hyperparathyroidism and autosomal dominant hypocalcemia. Patients afflicted with these disorders often suffer from osteoporosis, develop kidney stones and even present with neurological problems if left unabated. Alternatively, patients undergoing frequent hemodialysis as a result of chronic kidney disease, commonly present with secondary hyperparathyroidism (SHPT), where calcium and parathyroid levels are elevated. The only available CaSR allosteric agonist, cinacalcet HCl, is indicated for renal dialysis patients suffering from SHPT and functions by making CaSR more active. Our research focuses on the mechanisms involved in the regulation of CaSR in hopes of providing novel therapeutics to calcium-handling disorders.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Pennsylvania, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
214171
Name
Grant Michael
Region
Pennsylvania
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Trafficking Defines Plasma Membrane Levels of the Human Calcium-Sensing Receptor
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$145,833
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Calcium-Sensing Receptor; Endocytosis; Exocytosis; G-Protein Coupled Receptors; Total Internal Reflection Microscopy; Trafficking
Abstract
Calcium plays important roles in the functioning of the heart, muscle, brain, maintenance of bone structure, blood clotting and cell adhesion. It is no wonder that calcium levels are maintained within a narrow range, a property achieved primarily by parathyroid hormone, synthesized and secreted by the parathyroid glands. Parathyroid hormone functions to elevate calcium levels in the blood by a direct action on bone through resorption and on the kidneys causing calcium reabsorption from renal infiltrate. It also functions indirectly facilitating the conversion of vitamin D to its active form, potentiating the absorption of calcium from the gut. The main factor regulating the secretion of PTH is the calcium-sensing receptor (CaSR), which rapidly responds to small changes in blood calcium levels. Calcium-handling disorders may arise when CaSR is mutated, as appears in cases of familial hypocalciuric hypercalcemia/neonatal severe hyperparathyroidism and autosomal dominant hypocalcemia. Patients afflicted with these disorders often suffer from osteoporosis, develop kidney stones and even present with neurological problems if left unabated. Alternatively, patients undergoing frequent hemodialysis as a result of chronic kidney disease, commonly present with secondary hyperparathyroidism (SHPT), where calcium and parathyroid levels are elevated. The only available CaSR allosteric agonist, cinacalcet HCl, is indicated for renal dialysis patients suffering from SHPT and functions by making CaSR more active. Our research focuses on the mechanisms involved in the regulation of CaSR in hopes of providing novel therapeutics to calcium-handling disorders.
Competitiondate
201010
Approvedterm2
2 yrs 11 mths
Pinamesdelim
Grant, Michael
Approvedterm
2 ans 11 mois
Cihrcontribution2
~ $145,833~ $0~